Status:
TERMINATED
Assessment of Quadriceps Muscle Electrostimulation Used in Patients Suffering From Cystic Fibrosis
Lead Sponsor:
University Hospital, Grenoble
Collaborating Sponsors:
Vaincre la Mucoviscidose
Conditions:
Cystic Fibrosis
Mucoviscidosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is an add-on, randomized, open label, clinical trial that evaluates the use of quadriceps electrostimulation as an additional retraining procedure in patients suffering from cystic fibrosis.
Detailed Description
Cystic fibrosis is an autosomal recessive genetic disease due to a mutation of the CFTR protein gene. The CFTR protein transports chloride ions (Cl-) across cell membranes in the lungs, pancreas, dige...
Eligibility Criteria
Inclusion
- Age \>= 18 years
- Patient suffering from cystic fibrosis
- Patient has at least three measures of maximum expiratory volume per second \<= 45% of the theory among the 6 last measures performed
- Affiliation to French social security
- Capacity to consent
Exclusion
- Pregnant women
- Contraindication to application of magnetic field
- Pacemaker
- History of neurosurgical intervention
- Presence of metallic particles near the stimulation site.
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2010
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00391703
Start Date
October 1 2006
End Date
September 1 2010
Last Update
November 11 2010
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Pneumology Department of Grenoble University Hospital
Grenoble, Isere, France, 38043
2
Pneumology Department of Lyon University Hospital
Lyon, Rhone, France, 69000